title: Will this trial change my practice? The Dual Antiplatelet Therapy (DAPT) study - 12 or 30 months of dual antiplatelet therapy after drug-eluting stents.
authors.affiliation: University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: Maik J
authors.initials: MJ
authors.lastname: Grundeken
authors.forename: Alexandra
authors.initials: A
authors.lastname: Lansky
authors.forename: Jean-Francois
authors.initials: JF
authors.lastname: Tanguay
authors.forename: Anthony
authors.initials: A
authors.lastname: Gershlick
authors.forename: Andreas
authors.initials: A
authors.lastname: Baumbach
authors.forename: Thomas
authors.initials: T
authors.lastname: Cuisset
mesh_terms: D000369:Aged, 80 and over; D054855:Drug-Eluting Stents; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013988:Ticlopidine / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine